TCT-755 Beneficial Vascular Remodeling and Hemodynamic Improvement following Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension  by Kinutani, Hiroto et al.
occurred.Pearson correlation and linear regression showed higher correlation with ECT
than ACT to bivalirudin concentration (r0.859 versus 0.824, p0.001; r-sq 0.73 versus
0.68, p0.24).
Conclusions: Helena Laboratories Point-of-care DTM assay has higher correlation with
bivalirudin concentration across a wide range of doses com.ECT monitoring of bivaliru-
din may help reduce both thrombotic and bleeding complications in patients undergoing
PCI.
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Impact of bivalirudin on peri-procedural events in patients undergoing
rotational atherectomy: a subanalysis of the randomized ROTAXUS trial
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Background: Percutaneous coronary intervention (PCI) with rotational atherectomy
(RA) is associated with a high incidence of peri-procedural myocardial infarction (MI)
and local vascular complications. While bivalirudin has emerged as an attractive
alternative to heparin in patients undergoing contemporary PCI, it is unclear if such a
strategy has advantages in patients undergoing RA.
Methods: ROTAXUS randomly assigned 240 patients with calcified coronary lesions to
RA followed by stenting (n120) or stenting without RA (n120, standard therapy
group). Stenting was performed using a polymer-based paclitaxel-eluting stent. Proce-
dural anticoagulation therapy was determined by the treating physician. For the current
analysis, patients receiving bivalirudin (n129) were compared to those receiving
unfractionated heparin (UFH, n111) during PCI. Efficacy was assessed by the frequency
of peri-procedural MI according to the universal MI definition (Troponin T elevation 3
times the 99th percentile URL). Safety was assessed by the frequency of major access site
bleeding (ASB) according to the ACUITY trial definition.
Results: Baseline characteristics were similar in the bivalirudin and UFH groups. All
patients were preloaded with aspirin and clopidogrel. Glycoprotein IIb/IIIa inhibitors were
used in 1 patient in the bivalirudin group and 3 patients in the UFH group (p0.24).
Peri-procedural MI occurred less frequently in the bivalirudin compared to the UFH group
(22% vs. 37.5%, p0.02), while ASB was similar (2.3% vs. 5.5%, p0.20). There was
an interaction between the use of RA and bivalirudin regarding both efficacy and safety
endpoints. In the RA group, bivalirudin significantly reduced the incidence of peri-
procedural MI (15.7% vs. 38.7%, p0.01) with a strong trend towards reduced major
ASB (2.9 vs. 10.2%, p0.09) compared with UFH. In the standard therapy group,
bivalirudin was similar to UFH regarding peri-procedural MI (28.6% vs. 36.6%, p0.42)
and major ASB (1.7 vs. 1.7%, p1.0).
Conclusions: This analysis suggests the existence of an interaction between PCI with RA
and bivalirudin therapy, with significantly less peri-procedural MI and fewer access-site
complications with bivalirudin compared to UFH.
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Efficacy and Safety of Balloon Pulmonary Angioplasty for Peripheral Type
Chronic Thromboembolic Pulmonary Hypertension.
Yu Taniguchi1, Noriaki Emoto1, Hiroto Kinutani2, Hiromasa Otake1,
Toshiro Shinke1, Junya Shite1, Kenichi Hirata1
1Kobe University Graduate School of Medicine, Kobe-city, Hyogo, 2Kobe
University Graduate School of Medicine, Kobe, Hyogo
Background: Pulmonary thromboendarterectomy has been a definitive option for central
type of Chronic Thromboembolic Pulmonary Hypertension (CTEPH). However, patients
with thromboembolism in the peripheral segments have shown poor prognosis, because
such lesions are surgically inaccessible. Therefore, we performed an innovative new
approach of balloon pulmonary angioplasty (BPA) for inoperable CTEPH cases and
evaluated the efficacy and safety of this treatment.
Methods: We performed 34 sessions of BPA for 11 patients who suffered from
inoperable peripheral type of CTEPH with mean pulmonary artery pressure (mPAP) 
25mmHg and WHO functional class (WHO-Fc) III or IV in spite of under medical
therapy with Bosentan, Sildenafil, or Tadarafil. We evaluated hemodynamic parameters
by Swan-Ganz catheter pre oral medical therapy, pre and post BPA. BPA was repeated
in 16 sessions to every patient depending on their severity.
Results: Medical treatment performed before BPA did not improve hemodynamic
parameters (Table). However, BPA dramatically improved hemodynamic parameters
such as a significant increase in Cardiac output (CO) and decrease in mPAP and
pulmonary vascular resistance (PVR), which are accompanied with improved 6 minutes
walk distance and WHO-Fc after BPA therapy. On the other hand, reperfusion pulmonary
injury occurred in 18 sessions after BPA with 2 sessions required emergent intubation due
to hemorrhagic pulmonary edema. There were no mortal complications.
Pre medical
treatment Pre BPA Post BPA P value
CO
(L/min)
3.771.11 3.690.91 5.461.24 0.0027
mPAP
(mmHg)
37.27.7 38.37.7 20.93.7 0.0001
PVR
(dyne/cm5)
731.0351.6 693.8363.2 235.1137.4 0.0008
6MWD (m) 307.18.2 272.496.9 486.073.3 0.0122
WHO Fc 3.270.47 3.090.54 1.450.52 0.0001
Conclusions: BPA could be an effective treatment option for inoperable peripheral type
CTEPH to achieve dramatic improvement of hemodynamic and outcome parameters.
Further technical modification in attempting to reduce procedural complications will be
required.
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Beneficial Vascular Remodeling and Hemodynamic Improvement following
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary
Hypertension
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Toshiro Shinke1, Junya Shite1, Kenichi Hirata1
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Background: Recently the efficacy of the Balloon Pulmonary Angioplasty (BPA) for
Chronic thromboembolic pulmonary hypertension (CTEPH) have been reported. The
objective of this study was to reveal the late response of pulmonary artery diameter and
hemodynamics after BPA.
Methods: BPA was successfully performed for 9 CTEPH patients (23 sessions, average
2.61.0 sessions per patient). Quantitative Angiography (QA) and right heart catheter-
ization were performed pre, post and at chronic phase (112.448.2 days) after BPA.
Results: Immediately after BPA, mean pulmonary arterial pressure (mPAP) and
pulmonary vascular resistance (PVR) showed slight decrease, followed by significant
drop at chronic phase after BPA. QA revealed that minimal lumen diameter at ballooning
site (MLD-b) and 10 mm distal segment to balloon inflation site (MLD-d) significantly
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increased immediately after BPA. Both MLD-b and MLD-d further increased at chronic
phase (figure).
Conclusions: BPA achieves beneficial vascular remodeling at distal segment as well as
ballooning site, which is associated with chronic improvement in pulmonary artery
resistance.
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Role of Trellis Catheter in the Treatment of IVC Filter Thrombosis
Mohsen Sharifi1, Curt Bay2, Suzanne Bentz3, Mahshid Mehdipour3, Pamela Eden3,
Sasan Nowroozi3
1Arizona Cardiovascular Consultants & A.T. Still University, Mesa, AZ, 2A.T.Still
University, Mesa, AZ, 3Arizona Cardiovascular Consultants, Mesa, AZ
Background: Acute deep venous thrombosis (DVT) responds favorably to various
thrombectomy devices including Trellis (Covidien). In patients with an IVC filter,
occasionally massive bilateral DVT may occur with frequent involvement of the filter.
The role of Trellis in the treatment of IVC filter thrombosis (IVCFT) has not been
investigated.
Methods: Fifty two patients with IVCFT underwent treatment with Trellis as part of the
percutaneous endovenous intervention (PEVI) strategy(Fig.1). All had bilateral lower
extremity and iliac DVT and were quite symptomatic. For initial treatment an 8 F Trellis
system was used in all with administration of 10 mg of tPA via the Trellis catheter. The
device was activated inside the filter.Following the procedure venography was obtained to
assess the outcome.
Results: No patient achieved complete resolution of IVCFT with Trellis thrombectomy
alone. Partial resolution was achieved in only 8 patients. The remaining 44 patients had
no meaningful improvement and required catheter-directed thrombolysis (CDT) with tPA
for a mean duration of 328 hours. With CDT complete or substantial resolution of
IVCFT was achieved. There was no symptomatic pulmonary embolism as a result of
PEVI.
Conclusions: IVCFT is associated with bilateral iliac and femoropopliteal DVT. Trellis
thrombectomy alone has a limited role in its management and most patients require CDT.
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Rapid resolution of right ventricular dysfunction using ultrasonic
thrombolysis in massive and submassive pulmonary embolism patients
Tod Engelhardt1
1East Jefferson General Hospital, Metairie, LA
Background: Acute pulmonary embolism (PE) is a potentially fatal condition. Recent
studies demonstrate support for advanced treatment, especially in patients who present
with systemic hypotension (massive PE) and those who are normotensive but show signs
of RV dysfunction (submassive PE), leading to poor outcomes if inadequately treated.
This study assesses the hemodynamic effects of ultrasound accelerated thrombolysis
(USAT), an emerging catheter-based modality, among these patients in resolving the
thrombus and restoring cardiopulmonary function.
Methods: We retrospectively evaluated consecutive PE patients treated using USAT
(EkoSonic Endovascular System, EKOS Corporation) with recombinant tPA at East
Jefferson General Hospital from 2009 to 2011. All patients presented with signs of acute
PE and received chest CT scans for confirmation of PE. Follow-up CT was performed at
3923 hours after USAT. RV dysfunction was characterized by the right-to-left
ventricular dimension (RV/LV) ratio. Thrombus burden was assessed using the modified
Miller Score. All CT measurements were performed by an independent core laboratory.
Results: Among the 42 patients (age 5816 yrs) evaluated, 7 were massive and 35 were
submassive PE cases. 37 patients (88%) presented with bilateral PE. Overall, the mean
tPA dose was 31.016.6 mg infused over 19.06.8 hours. Following USAT, the RV/LV
ratio was reduced from 1.480.42 to 0.960.18 (p.001) and the modified Miller Score
from 18.05.1 to 9.75.3 (p.001) at follow-up CT. Patients treated early in the series
(n13) using a total dose of45 mg tPA did not show greater reduction in RV/LV ratio
or Miller Score than those later in the series (n29) using a total dose of 20 mg tPA
(p.38). Median length of stay was 1 day in the ICU and 7 days in the hospital. All
patients were discharged alive. There were no systemic bleeding complications, but 4
access site bleeding complications requiring transfusion and 1 suspected recurrent
massive PE event, all reported in the higher tPA dose group.
Conclusions: For massive and submassive PE, treatment by USAT rapidly reduced RV
dilatation and pulmonary clot burden with minimal risk of bleeding, allowing restoration
of cardiopulmonary function.
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Percutaneous Thrombectomy with Right Coronary Judkins 8 French Guide
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Background: Acute high risk pulmonary embolism carries a high degree of morbidity/
mortality and proper and rapid actions must be taken, this study aims to demonstrate how
to recover the patency of the pulmonary arteries by thrombus aspiration with right
coronary guide catheter in order to improve the function of the right ventricle and reduce
mortality.
Methods: A total of 38 patients, 20 female, 18 male, ages 28 to 64 years with high risk
acute pulmonary embolism were studied from March 2009 to April 2012. In all patients
the pulmonary obstruction was bilateral, the degree of obstruction was greater than 80%
of the main branches. The diagnosis was formulated with pulmonary angiotomography
echocardiogram. By percutaneous puncture of the femoral vein an 8 French by 80cm in
length metal sheath was advanced to the trunk of the pulmonary artery, a #4 Judkins right
coronary guide catheter was advanced trough the introducer to the site of thrombosis and
a 20ml syringe connected and vacuum sustained trough the catheter while slowly
withdrawing it, subsequently the catheter was extracted and purged to extract the aspirated
thrombi. This maneuver was repeated several times and finally angiography with this
catheter was perform to confirm the patency of the pulmonary branches.
Results: Extraction of thrombus was achieved in all cases. permeability of the pulmonary
branches was obtained in 80% of the cases, saturation and blood pressure were restored
in the next few hours. One patient (2.63%) died during the procedure and another patient
had hemoptysis.
Conclusions: This is an effective technique for the treatment of high-risk acute
pulmonary embolism reproducible at low-cost and capable to reestablish blood pressure,
oxygen saturation and right ventricular function and decrease morbidity significantly.
TCT-759
Ultrasound-Accelerated Thrombolysis for the Treatment of Acute Pulmonary
Embolism
Matthew Wiisanen1, Joseph Foley1, John Gurley1
1University of Kentucky, Lexington, KY
Background: Acute pulmonary embolism (PE) is a major cause of death. 90-day
mortality rates are 58% for massive PE (with cardiogenic shock) and 22% for submassive
PE (right heart strain without shock). Systemic thrombolysis improves hemodynamic
stability but is associated with major bleeding in 20% of patients. Alternative therapies for
acute PE are needed. This study examines the safety and effectiveness of catheter-directed,
ultrasound-accelerated thrombolysis (USAT) in patients with PE.
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